Freeline Therapeutics

NASDAQ: FRLN · Real-Time Price · USD
6.49
0.01 (0.15%)
At close: Feb 16, 2024, 9:37 PM

Freeline Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.32 -0.5
PEG Ratio
0.01 0.01
PS Ratio
n/a n/a
PB Ratio
0.54 0.59
P/FCF Ratio
-0.33 -0.63
P/OCF Ratio
-0.36 -0.66
OCF/S Ratio
n/a n/a
Debt / Equity Ratio
0.11 n/a
Quick Ratio
1.61 5.89
Current Ratio
2.18 6.20
Asset Turnover
n/a n/a
Interest Coverage
n/a n/a
Return on Equity
-1.7 -1.17
Return on Assets
-1.03 -0.99
Return on Invested Capital
-1.69 -1.19
Dividend Yield
n/a n/a
Payout Ratio
n/a n/a
Gross Profit Margin
n/a n/a
Net Profit Margin
n/a n/a
Pretax Profit Margin
n/a n/a
Operating Profit Margin
n/a n/a
FCF Margin
n/a n/a
EBITDA Margin
n/a n/a